Featured Research

from universities, journals, and other organizations

Folic acid for everybody? Arguments in favor of food fortification to reduce neural tube defects

Date:
April 28, 2011
Source:
Deutsches Aerzteblatt International
Summary:
Neural tube defects in neonates are common in Germany compared with the rest of Europe. Extensive folic acid fortification of foods in Germany might prevent these in 85–100% of cases, researchers argue.

Neural tube defects in neonates are common in Germany compared with the rest of Europe. Extensive folic acid fortification of foods in Germany might prevent these in 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue in this issue of Deutsches Δrzteblatt International.

A woman's folic acid intake before and during early pregnancy ensures that the fetus does not develop the neural tube defect commonly known as spina bifida. Every year, 800 pregnancies in Germany are diagnosed with a neural tube defect. Most of those pregnancies are terminated.

However, the mandatory fortification of foods with folic acid is subject of controversy in Germany. Overdosages of folic acid are suspected of accelerating the growth of certain cancers. Herrmann and Obeid evaluate different international studies and show that this suspicion is not supported by the evidence. No association was found, for example, for the observed increase in the number of patients with colorectal cancer after folic acid fortification programs started in the United States and Canada. According to Herrmann and Obeid, the increase can be explained by improved early detection programs during this time period.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wolfgang Herrmann and Rima Obeid. The mandatory fortification of staple foods with folic acid: A current controversy in Germany. Dtsch Arztebl Int, 2011; 108(15): 249%u201354 DOI: 10.3238/arztebl.2011.0249

Cite This Page:

Deutsches Aerzteblatt International. "Folic acid for everybody? Arguments in favor of food fortification to reduce neural tube defects." ScienceDaily. ScienceDaily, 28 April 2011. <www.sciencedaily.com/releases/2011/04/110428092459.htm>.
Deutsches Aerzteblatt International. (2011, April 28). Folic acid for everybody? Arguments in favor of food fortification to reduce neural tube defects. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110428092459.htm
Deutsches Aerzteblatt International. "Folic acid for everybody? Arguments in favor of food fortification to reduce neural tube defects." ScienceDaily. www.sciencedaily.com/releases/2011/04/110428092459.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins